Financials

News Ideas Minds Technicals Forecast

I9DN fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of ARBUTUS BIOPHARMA CORP

Total assets of I9DN for Q1 24 is 139.29 M EUR, 6.46% more than the previous Q4 23. And total liabilities decreased by 4.98% in Q1 24 to 33.04 M EUR.

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: EUR

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—